CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Home-use Test and Follow-up QuestionnaireWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)

Name (Synonyms) Correlation
drug361 BNT162c2 Wiki 1.00
drug358 BNT162a1 Wiki 1.00
drug359 BNT162b1 Wiki 0.71
drug360 BNT162b2 Wiki 0.71

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D012327 RNA Virus Infections NIH 0.45
D012141 Respiratory Tract Infections NIH 0.19
D014777 Virus Diseases NIH 0.12
D003141 Communicable Diseases NIH 0.08
D007239 Infection NIH 0.05

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0011947 Respiratory tract infection HPO 0.19

There is one clinical trial.

Clinical Trials

1 Singapore COVID-19 Chemosensory Tracking (SCCT) Study

The study aims to longitudinally track the onset, severity and recovery of changes in chemosensory acuity (smell and/or taste loss) among those suspected of COVID-19 infection. Using standardised questionnaire and testing approaches, the investigators aim to objectively characterise and measure temporal changes in taste and smell to confirm the prevalence of these symptoms as an early marker of infection. Information on symptoms experience, changes in appetite and food-related quality of life will be also be assessed via questionnaire. The results of the study will help individuals who experience a loss of smell and/or taste to self-isolate and/or self-refer to a medical professional, if an association between smell and/or taste and COVID-19 infection is found.

NCT04492904 Covid19 Other: Home-use Test and Follow-up Questionnaire

Primary Outcomes

Description: Taste and smell functions of all participants will be assessed as part of the Home-use Test using taste test items (i.e. sweet: sugar, salty: salt, sour: lime powder and bitter: coffee powder) and odour pens respectively. Participants will identify the taste/smell and rate the perceived intensity on a Visual Analogue Scale (VAS) from 'not strong at all' (0) to 'extremely strong taste/smell' (100). A higher score will indicate greater intensity of taste/smell perceived.

Measure: Taste and smell acuity

Time: 28 days

Secondary Outcomes

Description: Experienced symptoms, changes in appetite and food-related quality of life will be assessed as part of the Follow-up questionnaire.

Measure: Experienced symptoms, changes in appetite and food-related quality of life

Time: 28 days

No related HPO nodes (Using clinical trials)